Goal : Actualité Goal en direct - P1 | Bourse Reflex
Accueil > Tags > Goal

  • Toutes les actualités en rapport avec « Goal »

26/04 18:00 Goal - THERANEXUS ANNOUNCES ITS 2017 ANNUAL RESULTS AND PRESENTS AN UPDATE ON THE PROGRESS OF ITS CLINICAL TRIALS

26/04 17:45 Goal - 2017/2018 revenues EUR 472.1 million

26/04 17:45 Goal - SES-imagotag: Q1 2018 Sales

19/04 18:00 Goal - ATEME REVEALS 3 MAJOR INNOVATION PRIORITIES AT NAB 2018

19/04 17:45 Goal - Quantum Genomics enters a new phase of maturity with its BAPAIs Fast Growth strategic plan

09/04 18:00 Goal - Quantum Genomics strengthens its governance

06/04 15:35 Goal - Crypto CrossinG(R): WALLIX and Bertin IT are joining forces to create a highly secure email gateway for the exchange of sensitive data

03/04 07:00 Goal - Groupe Gorgé: 2017 - a year of contrasts

29/03 18:00 Goal - Quantum Genomics publishes its financial results for the year 2017

29/03 11:00 Goal - 2017 RESULTS: STRONG REVENUE GROWTH, PROFIT GENERATED IN SECOND HALF NEW STRATEGIC PLAN AND PLANNED SHARE ISSUE

13/03 18:30 Goal - Résultats annuels 2017

12/03 17:45 Goal - 2017 RESULTS

05/03 18:30 Goal - Quantum Genomics Secures Operational Flexibility and Growth Capital through Equity Line Financing with Kepler Cheuvreux

27/02 08:15 Goal - FIGEAC AERO, TASNEE, AL SALAM AEROSPACE INDUSTRIES CO AND INDUSTRIAL CLUSTERS SIGN A COOPERATION AGREEMENT IN SAUDI ARABIA

23/02 07:00 Goal - Prodways Group's revenue for Q4 and full year 2017 : Continued strong upward trend on financial year 2017 (up 38%)

23/02 07:00 Goal - Increase in Groupe Gorgé's revenue in the fourth quarter of 2017, strong growth in 3D printing division

14/02 18:00 Goal - SES-imagotag and Panasonic announce retail digitisation partnership in Europe

29/12 14:30 Goal - Quantum Genomics to Present at Biotech Showcase 2018

14/12 07:30 Goal - Creation of Paragon ID, a European leader for identification solutions for e-ID, Smart Cities and the Internet of Things

15/11 07:30 Goal - Quantum Genomics announces recruitment of first patients in the NEW-HOPE arterial hypertension study in the United States